+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SAMPRE SAMPRE

Sampre Nutritions Share Price

₹6.37 -0.26 (-3.92%)
84.95% Fall from 52W High

07 Sep, 2026 3:26 PM (IST)

Sampre Nutritions live price: ₹6.37. It opened at ₹7 vs previous close ₹7; intraday high/low: ₹7/₹6. The 50 & 200 DMA stand at ₹6.90/₹13.60.

Sampre Nutritions Performance

  • Today's Low
  • ₹6
  • Today's High
  • ₹7
  • 52 Week Low
  • ₹5
  • 52 Week High
  • ₹42
  • Open Price₹7
  • Previous Close₹7
  • Volume1,272,554
  • 50 DMA₹6.90
  • 100 DMA₹9.80
  • 200 DMA₹13.60

Sampre Nutritions Chart

Investment Returns

  • Over 1 Month + 23.21%
  • Over 3 Month -44.7%
  • Over 6 Month -66.4%
  • Over 1 Year -70.6%

Smart Investing Starts Here Start SIP with Sampre Nutritions for Steady Growth!

Invest Now

Sampre Nutritions Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 16.9
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 56
  • P/B Ratio
  • 0.5
  • Average True Range
  • 0.4
  • EPS
  • 0.4
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • 62.19
  • MFI
  • 78.52

Latest Stock News Updates

Sampre Nutritions Ltd - 530617 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Consolidated Voting Results with the Scrutinizers Report for the 35th Annual General Meeting.

Sampre Nutritions Ltd - 530617 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Proceedings of the 35th AGM conducted through Video Conferencing ("VC") / Other Audio-Visual Mode ("OAVM")

Sampre Nutritions Ltd - 530617 - Announcement under Regulation 30 (LODR)-Preferential Issue

Receipt of in-principle / prior approval from BSE for issuance and allotment of 1770710 equity shares of INR 5 each at a price not less than INR 42 each to promoter against conversion of unsecured loans on a preferential basis.

Sampre Nutritions Financials

Sampre Nutritions Technicals

EMA & SMA

Current Price
₹6.37
-0.26 (-3.92%)
pointer
  • Bearish Moving Average 6
  • Bullish Moving Average 10
  • 20 Day
  • ₹5.90
  • 50 Day
  • ₹6.90
  • 100 Day
  • ₹9.80
  • 200 Day
  • ₹13.60

Resistance and Support

6.56 Pivot Speed
  • R3 6.60
  • R2 6.60
  • R1 6.60
  • S1 6.60
  • S2 6.60
  • S3 6.60

Sampre Nutritions Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-05 Quarterly Results & A.G.M.
2026-05-29 Audited Results
2026-02-13 Quarterly Results
2025-11-05 Quarterly Results & Others Inter alia, to consider 1. Preferential issue of shares. 2. Approve to issue equity shares by way of sweat equity; and conversion of loan into equity shares.
2025-10-03 Others Inter-alia, to consider 1. To offer, issue and allot securities by way of preferential allotment. 2. To approve issuance of foreign currency convertible bonds (FCCBs).
Date Purpose Remarks
2025-11-14 Split Stock split from Rs. 10/- to Rs. 5/-.
Date Purpose Remarks
2025-11-14 Bonus Bonus issue of equity shares in the ratio of 1:1 of Rs. 5/-.

Sampre Nutritions Shareholding Pattern

85.96%
14.04%
0%

About Sampre Nutritions

Sampre Nutritions is an Indian public company. Specializing in the manufacturing of sugar-boiled candies, toffees, eclairs, center-filled items, and healthcare/powder confectionery products. View More
  • NSE Symbol
  • SAMPRE
  • BSE Symbol
  • 530617
  • ISIN
  • INE375C01022

Similar Stocks to Sampre Nutritions

Sampre Nutritions FAQs

Sampre Nutritions share price is ₹6 As on 07 September, 2026 | 15:14

The Market Cap of Sampre Nutritions is ₹55.7 Cr As on 07 September, 2026 | 15:14

The P/E ratio of Sampre Nutritions is 16.9 As on 07 September, 2026 | 15:14

The PB ratio of Sampre Nutritions is 0.5 As on 07 September, 2026 | 15:14

The 52 week High & Low of Sampre Nutritions is ₹42.3/₹4.5 respectively As on 07 September, 2026 | 15:14

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23